A great starting point for your AbCellera Biologics research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision. Multiple analysts have issued price targets for $ABCL recently. We have seen 4 analysts offer price targets for $ABCL in the last 6 months, with a median target of $10.0. In institutional briefings, ABCL stock forecast 2025 is framed around market share capture in the antibody discovery niche. Analysts stress the importance of expanding licensing deals for predictable quarterly cash flows.
